Clinical trial
Treatment of Pediatric Hypertension With Altace Trial
NCT00044265 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00044265 |
|---|---|
| Title | Treatment of Pediatric Hypertension With Altace Trial |
| Official title | A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | ramipril |
| Enrollment | 310 |
| Start date | Jul 1, 2002 |
| Completion | Nov 1, 2004 |
| First posted | Aug 26, 2002 |
| Last update posted | Jun 7, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: